From nuclear imaging diagnostics that reveal the finest details of the heart, to Big Data and meta-analytical methods that expose the human health ecosystem from a bird’s-eye view. Where risk and reward prospects can be identified and evaluated, the frontiers of cardiac biotechnology advance ever faster into the future, with clinical procedures, care valuations, and improvements in patient outcomes close behind.

Leading the Fight…

Significantly, interdisciplinary studies like that described in the consensus statement document of Chareonthaitawee, et al., point toward further breakthroughs in the near future as new strands of inquiry weave themselves together out of separate but complementary scientific and medical traditions and methods.

…Against the Leading Cause of Death

For cardiac care, against the spectrum of pathologies associated with heart disease and stroke, collectively the most harmful of diseases, the health sciences and health care industry have produced some of the most advanced medical hardware and software engineerings to support cardiovascular interventions.

Also, technical advances are merging with data sets and powerful analytical models. Electronic health records for patient and population health data provide increasingly substantial timelines for longitudinal evaluations and comparisons of multiple sets of variables.

State-of-the-Art Heart Medicine

These twin healthcare innovation engines are producing some of the most advanced evidence-based interventions, techniques, and technology tools in medicine today. And the results are showing up in the patient outcomes in cardiac clinics and catheter labs around the country.

Death rates from heart disease and stroke have fallen substantially in the last 50 years, and continue to progress along that trend. Among many possible examples of the science behind these improvements, “Deferred or Immediate Stent Implantation for Primary Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials” (A.N. Mahmoud et al.) offers an excellent model of clinical data working in concert with clinical technology to save lives.

Interim Leadership Advancing Cardiac Care

From the NHS Solutions team of interim hospital management professionals, experienced clinical directors and senior hospital leaders can marshal these research results and technology resources to make a significant impact in catheter lab and cardiac service performance. Talk with our staffing experts today about an opportunity that’s right for you.